AKT1 and glioblastoma: Furthermore, the investigation indicates that the compound-1H exerts its anti-glioblastoma efficiency through significant inhibition of Raf/MEK/ERK and PI3K/AKT signaling pathways, which accelerates our comprehension on the molecular mechanisms of the compound-1H in human glioblastoma cells.